The AI in oncology market is poised for significant growth driven by increasing oncological data complexity, demand for personalized medicine, and advancements in AI technology. Key opportunities lie in software solutions and services for various cancer types. The market is led by major players like Google and IBM, with expansion potential across global regions.
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) — The “AI in Oncology Market 2025-2029” has been added to ResearchAndMarkets.com’s offering.
The AI in oncology market is anticipated to expand significantly, with an expected growth of USD 7.54 billion from 2024 to 2029, reflecting a CAGR of 27.8% within the forecast period. This comprehensive analysis highlights key market dimensions, growth drivers, emerging trends, and vendor insights, covering approximately 25 prominent vendors.
Key market dynamics include the increasing volume and complexity of oncological data, a growing emphasis on personalized medicine and precision oncology, alongside rapid advancements in AI and computational infrastructure. These factors are pivotal in driving market expansion.
Emerging trends such as the rise of multimodal AI and integrated diagnostics are catalyzing growth in the AI in oncology market. There is also a burgeoning focus on clinical workflow integration and scalability, with increased regulatory scrutiny and the demand for real-world evidence driving significant market demand.
Utilizing a blend of primary and secondary data from crucial industry players, the report provides an all-encompassing examination of market size, regional segmentation, and vendor landscape, including historical and forecast data.
Market Segmentation Overview:
By Component:
Software Solutions
Services
By Type:
Breast Cancer
Lung Cancer
Kidney Cancer
Others
By Application:
By Geographic Landscape:
North America
Europe
APAC
South America
Middle East and Africa
Report Coverage Areas:
AI in Oncology Market Sizing
AI in Oncology Market Forecast
AI in Oncology Market Industry Analysis
A detailed vendor analysis is incorporated to aid clients in enhancing their market positioning.
The report thoroughly evaluates key vendors such as:
BenevolentAI
ConcertAI Inc.
F. Hoffmann La Roche Ltd.
Freenome Holdings Inc.
GE Healthcare Technologies Inc.
Google LLC
International Business Machines Corp.
Koninklijke Philips N.V.
Lunit Inc.
Microsoft Corp.
NVIDIA Corp.
Owkin Inc.
PAIGE LLC
PathAI Inc.
Recursion Pharmaceuticals Inc.
Siemens Healthineers AG
SOPHiA GENETICS
Tempus Labs Inc.
